News

Shares of Phio Pharmaceuticals PHIO rallied 52.5% on Wednesday after the company announced that the Safety Monitoring ...
While skin cancer rates are growing in many parts of the world, experts disagree on whether this represents a true epidemic ...
The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...
Laryngeal cancer affects the larynx (voice box) and often can be curable. Here are the treatment and surgical options and how ...
HPV driven cancers, including HPV+ HNSCC, are characterized by defects in the DDR pathway, making them potentially susceptible to WEE1 inhibition. HPV+ cancers are those where the underlying cause is ...
A phase 1b trial is evaluating PH-762 for the treatment of cutaneous squamous cell carcinoma, melanoma and Merkel cell ...
The Nonmelanoma Skin Cancer market is expected to experience substantial growth from 2024 to 2034, driven by increasing ...
Val Kilmer's official cause of death has been revealed as pneumonia but new details have also emerged. The actor, best known ...
An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...
The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...